Lung Protocol - ADVANCED - NON-SMALL CELL - S1403

A Randomized Phase II/III Trial of Afatinib plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients with Advanced, EGFR Mutation Positive Non-Small Cell Lung Cancer.